FDA Clearance Tracker · P150035-S013
Aveir Leadless System (Dual-Chamber)
Last checked: Nov 20, 2026Latest source record: Sep 25, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Sep 25, 2024
Approved
Time to decision
89 days
Received Jun 28, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150035-S013
- Device name
- Aveir Leadless System (Dual-Chamber)
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Jun 28, 2024
- Decided
- Sep 25, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150035
Device type
- Device type
- Leadless pacemaker (PNJ)
- Device class
- Class III
- Regulation
- 21 CFR 870.3610
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for a new dual-chamber functional operating mode (AAI(R)+VVI) for the Aveir DR Leadless Pacing System
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.